AGL 40.05 Decreased By ▼ -0.11 (-0.27%)
AIRLINK 129.74 Decreased By ▼ -1.99 (-1.51%)
BOP 6.68 Decreased By ▼ -0.01 (-0.15%)
CNERGY 4.62 Increased By ▲ 0.15 (3.36%)
DCL 8.85 Increased By ▲ 0.03 (0.34%)
DFML 41.91 Increased By ▲ 1.30 (3.2%)
DGKC 83.97 Decreased By ▼ -0.11 (-0.13%)
FCCL 32.70 Increased By ▲ 0.36 (1.11%)
FFBL 75.47 Increased By ▲ 6.86 (10%)
FFL 11.50 Increased By ▲ 0.15 (1.32%)
HUBC 110.50 Decreased By ▼ -1.26 (-1.13%)
HUMNL 14.65 Increased By ▲ 0.34 (2.38%)
KEL 5.40 Increased By ▲ 0.18 (3.45%)
KOSM 8.41 Decreased By ▼ -0.57 (-6.35%)
MLCF 39.89 Increased By ▲ 0.46 (1.17%)
NBP 60.45 Increased By ▲ 0.16 (0.27%)
OGDC 198.45 Increased By ▲ 3.51 (1.8%)
PAEL 26.63 Decreased By ▼ -0.06 (-0.22%)
PIBTL 7.71 Increased By ▲ 0.23 (3.07%)
PPL 158.00 Increased By ▲ 2.23 (1.43%)
PRL 26.69 Increased By ▲ 0.01 (0.04%)
PTC 18.40 Increased By ▲ 0.10 (0.55%)
SEARL 82.19 Decreased By ▼ -0.83 (-1%)
TELE 8.34 Increased By ▲ 0.11 (1.34%)
TOMCL 34.45 Decreased By ▼ -0.10 (-0.29%)
TPLP 9.14 Increased By ▲ 0.33 (3.75%)
TREET 17.32 Increased By ▲ 0.62 (3.71%)
TRG 61.30 Decreased By ▼ -1.15 (-1.84%)
UNITY 27.35 Decreased By ▼ -0.09 (-0.33%)
WTL 1.37 Increased By ▲ 0.09 (7.03%)
BR100 10,400 Increased By 213 (2.09%)
BR30 31,653 Increased By 316.8 (1.01%)
KSE100 97,328 Increased By 1781.9 (1.86%)
KSE30 30,192 Increased By 614.4 (2.08%)

KARACHI: The Pakistan Chemists and Druggists Association (PCDA) strongly condemned the imposition of an 18% general sales tax (GST) on alternative medicines and demanded immediate withdrawal. The tax hike is expected to increase prices by 20-25%, making these medicines unaffordable for the middle class.

A delegation from PCDA, led by Ghulam Hashim Noorani and Abdul Samad Budhani, met with Fayyaz Magon, Senior Vice President of the Federation of Pakistan Chambers of Commerce and Industry (FPCCI), to express their concerns. They urged the PCDA to play a role in getting the GST revoked.

The delegation explained that alternative medicines, including herbal and homeopathic remedies, are used by the middle class and are not subsidized by the government. The GST imposition will not only increase prices but also harm importers, traders, and retailers, potentially disrupting the distribution system and leading to a nationwide shortage of medicines.

The PCDA demanded that the government either provide subsidies and concessions to the pharmaceutical sector or exempt alternative medicines from GST, additional taxes, and withholding tax for non-filers. They called for immediate amendments to the Finance Bill and the issuance of an SRO to exempt medicines regulated under the DRAP Act and Medical Device Act from taxes.

The association warned that if the taxes are not withdrawn, it will lead to a significant increase in prices, making medicines unaffordable for the common man, and ultimately harming the public health.

Copyright Business Recorder, 2024

Comments

Comments are closed.